Lijun International Pharmaceutical (Holding) Co. Ltd.

Lijun International Pharmaceutical (Holding) Co., Limited (simplified Chinese: 利君国际医药(控股)有限公司; traditional Chinese: 利君國際醫藥(控股)有限公司) (SEHK: 2005) is a Wanchai, Hong Kong-based investment holding company with two pharmaceutical business segments:

Business segments

The Group was listed on Hong Kong Stock Exchange in December 2005 (stock code: 2005).

The Group is engaged in the research, development, manufacturing and selling of a wide range of finished medicines and bulk pharmaceutical products to hospitals and distributors, including antibiotics, intravenous infusion solution, non-antibiotics finished products, bulk pharmaceuticals and health care product.

Subsidiaries

The Company’s subsidiaries include:

  • New Orient Limited (New Orient) in Hong Kong
  • Shijiazhuang No. 4 Pharmaceutical Co., Limited, intravenous infusion solution manufacturer in Hebei Province (acquired in June 2007)
  • Xi’an Lijun Pharmaceutical Co., Limited (Xi’an Lijun), engaged in manufacturing pharmaceuticals in Shaanxi Province
  • Shenzhen Lijun Pharmaceutical Co., Limited, engaged in manufacturing pharmaceuticals in Guangdong Province.

The Company is the largest domestic manufacturer of macrolide antibiotics, with a leading position for its intravenous infusion solution products in high-end hospital market.

Facing more merger and acquisition opportunities from medical reform in China, the Group is positioned for continuous mergers and acquisitions to promote its growth.

gollark: It's not hard to ensure you get a breeding pair without that.
gollark: Why pinks?
gollark: What do you need for holidays? Incubates?
gollark: Extrapolating from 1 month or so for 50 dragons, and November being, what, 4 months away, I ought to be able to reach silver in time by doing the same stuff.
gollark: The codes are just long enough for `7ate9`, actually.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.